clinical trial · NCT06282614
Performance and Safety of MUCOGYNE® Ovule as a Moisturizer
Vaginal DrynessMucogyne Ovule
brief summary
The aim of this post-Market Clinical Follow-up (PMCF) study is to confirm the efficacy and safety of MUCOGYNE® Ovule in the maintainance of natural moisture of the vulvovaginal mucosa and in the compensation for any natural secretions deficiencies, when used in accordance with its approved labeling, in the context of vulvovaginal dryness.
started
Apr 11, 2024
primary completion
Feb 14, 2025
completion
Feb 14, 2025
last updated
Apr 13, 2025
official title
MOVHYDA (MUCO245) - Performance and Safety of MUCOGYNE® Ovule as a Moisturizer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol